Karen Chan
Associate
Works at SCI Ventures
Investor profile | Builders Republic
About
Associate at SCI Ventures in the UK, Karen Chan invests from Pre-Seed to Series A with check sizes ranging from €0.5 to €3 million, with a specialized thesis in biotech and life sciences stemming from her scientific background. She notably serves as a Board Observer at Mironid® Limited and FundaMental Pharma, and on the advisory board of H3 Health Hub. Her background combines academic research (PhD in biochemistry from the University of Cambridge, postdoc in drug discovery at Sanofi/Evotec-Fraunhofer) and investment (M Ventures, BGV).
Profile
- Role
- Associate
- Fund
- SCI Ventures
- Nationality
- British